Persistent portosystemic shunts after liver transplantation causing episodic hepatic encephalopathy.
Barritt
A Sidney
AS
Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599-7080, USA. abarritt@unch.unc.edu
Fried
Michael W
MW
Hayashi
Paul H
PH
D004359:Drug Therapy, Combination; D004621:Embolization, Therapeutic; D005260:Female; D006501:Hepatic Encephalopathy / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007792:Lactulose / Q000627:therapeutic use; D008102:Liver Circulation; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011168:Portal System / Q000503:physiopathology*; D011172:Portography; D012008:Recurrence; D012294:Rifamycins / Q000627:therapeutic use; D000078262:Rifaximin; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D018608:Ultrasonography, Doppler
D012294:Rifamycins; D007792:Lactulose; D000078262:Rifaximin